Purchases and Sales Made in Q3 2024 in Revance Therapeutics, Inc. (RVNC)
This table provides information about the institutional ownership of Revance Therapeutics, Inc. (RVNC) during Q3 2024. The information is specifically focused on institutions that hold shares of Revance Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Oct 29, 2024
Q3 2024
|
Silicon Valley Capital Partners
|
SELL
|
- |
-136KClosed |
$349K - $349K
|
0
$0
|
|
|
Nov 14, 2024
Q3 2024
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-153K- 90.84% |
$392K - $392K
|
15.4K
$39.5K
|
|
|
Nov 12, 2024
Q3 2024
|
Blair William & CO
Chicago, IL |
SELL
|
- |
-205K- 70.4% |
$526K - $526K
|
86K
$221K
|
|
|
Nov 12, 2024
Q3 2024
|
Dcf Advisers, LLC
Greenwich, CT |
SELL
|
- |
-231K- 92.23% |
$593K - $593K
|
19.4K
$49.9K
|
|
|
Nov 13, 2024
Q3 2024
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-261K- 4.35% |
$670K - $670K
|
5.73M
$14.7M
|
|
|
Nov 12, 2024
Q3 2024
|
Exodus Point Capital Management, LP
New York, NY |
SELL
|
- |
-317K- 71.69% |
$814K - $814K
|
125K
$321K
|
|
|
Nov 14, 2024
Q3 2024
|
High Tower Advisors, LLC
Chicago, IL |
SELL
|
- |
-388K- 72.47% |
$997K - $997K
|
147K
$379K
|
|
|
Nov 14, 2024
Q3 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-477K- 75.3% |
$1.23M - $1.23M
|
157K
$402K
|
|
|
Nov 14, 2024
Q3 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-601K- 56.89% |
$1.54M - $1.54M
|
455K
$1.17M
|
|
|
Nov 14, 2024
Q3 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-609K- 80.47% |
$1.57M - $1.57M
|
148K
$380K
|
|
|
Nov 12, 2024
Q3 2024
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-1.47M- 23.55% |
$3.79M - $3.79M
|
4.78M
$12.3M
|
|
|
Nov 13, 2024
Q3 2024
|
Stonepine Capital Management, LLC
Bend, OR |
SELL
|
- |
-1.98M- 70.71% |
$5.09M - $5.09M
|
820K
$2.11M
|
|
|
Nov 13, 2024
Q3 2024
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-2.24M- 100.0% |
$5.75M - $5.75M
|
9
$23.1
|
|
|
Dec 26, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-2.81M- 95.44% |
$7.22M - $7.22M
|
134K
$345K
|
|
|
Nov 08, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-2.81M- 95.44% |
$7.22M - $7.22M
|
134K
$345K
|
|
|
Nov 14, 2024
Q3 2024
|
Palo Alto Investors LP
Palo Alto, CA |
SELL
|
- |
-3.65M- 69.34% |
$9.37M - $9.37M
|
1.61M
$4.14M
|